Dose-finding Study for AdimrSC-2f Vaccine
NCT05104489
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
241
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
AdimrSC-2f
Sponsor
Adimmune Corporation